| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP5MC1 ATP5MC2 SLC32A1 SLC43A2 SPNS1 SLC38A10 CNNM2 ROMO1 SLC17A3 SLC12A9 SLC35A4 SLC39A1 SLC17A9 SLC35D2 SLC5A6 ABCB8 CYB561D2 SLC9B2 TMEM63C TMEM150C SLC17A7 SLCO3A1 SLC49A3 SLC52A2 SLC15A3 NDUFB4 SLC29A2 SLC16A7 SLC4A5 SLC29A1 SLC25A51 SVOPL SLC16A12 | 1.68e-25 | 1180 | 59 | 33 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | ATP5MC1 ATP5MC2 SLC32A1 SLC43A2 SPNS1 SLC38A10 CNNM2 ROMO1 SLC17A3 SLC12A9 SLC35A4 SLC39A1 SLC17A9 SLC35D2 SLC5A6 ABCB8 CYB561D2 SLC9B2 TMEM63C TMEM150C SLC17A7 SLCO3A1 SLC49A3 SLC52A2 SLC15A3 NDUFB4 SLC29A2 SLC16A7 SLC4A5 SLC29A1 SLC25A51 SVOPL SLC16A12 | 2.78e-24 | 1289 | 59 | 33 | GO:0005215 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC32A1 SLC17A3 SLC12A9 SLC17A9 SLC35D2 SLC5A6 ABCB8 CYB561D2 SLC9B2 SLC17A7 SLCO3A1 SLC15A3 NDUFB4 SLC16A7 SLC4A5 SLC29A1 SLC16A12 | 2.23e-14 | 477 | 59 | 17 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC32A1 SLC17A3 SLC12A9 SLC17A9 SLC35D2 SLC5A6 SLC9B2 SLC17A7 SLCO3A1 SLC15A3 SLC16A7 SLC4A5 SLC29A1 SLC16A12 | 1.33e-13 | 296 | 59 | 14 | GO:0015291 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC32A1 SLC43A2 SLC38A10 SLC17A3 SLC17A9 SLC35D2 SLC5A6 SLC17A7 SLCO3A1 SLC52A2 SLC16A7 SLC4A5 SLC16A12 | 2.48e-12 | 293 | 59 | 13 | GO:0008514 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP5MC1 ATP5MC2 SLC32A1 CNNM2 ROMO1 SLC17A3 SLC12A9 SLC39A1 SLC5A6 SLC9B2 TMEM63C SLC17A7 SLC15A3 NDUFB4 SLC4A5 SLC29A1 | 5.42e-11 | 664 | 59 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP5MC1 ATP5MC2 SLC32A1 CNNM2 ROMO1 SLC17A3 SLC12A9 SLC39A1 SLC5A6 SLC9B2 TMEM63C TMEM150C SLC17A7 SLC15A3 NDUFB4 SLC4A5 SLC29A1 | 7.44e-11 | 793 | 59 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP5MC1 ATP5MC2 SLC32A1 CNNM2 SLC17A3 SLC12A9 SLC39A1 SLC5A6 SLC9B2 TMEM63C SLC17A7 SLC15A3 NDUFB4 SLC4A5 SLC29A1 | 2.67e-10 | 627 | 59 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | symporter activity | SLC32A1 SLC17A3 SLC12A9 SLC5A6 SLC17A7 SLC15A3 SLC16A7 SLC4A5 SLC29A1 | 5.46e-10 | 150 | 59 | 9 | GO:0015293 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC32A1 SLC17A3 SLC12A9 SLC5A6 SLC17A7 SLC15A3 SLC4A5 SLC29A1 | 2.16e-09 | 119 | 59 | 8 | GO:0015294 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP5MC1 ATP5MC2 SLC32A1 CNNM2 SLC17A3 SLC12A9 SLC39A1 SLC5A6 SLC9B2 TMEM63C SLC17A7 SLC15A3 NDUFB4 SLC4A5 SLC29A1 | 3.59e-09 | 758 | 59 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC32A1 SLC17A3 SLC12A9 SLC5A6 SLC9B2 SLC17A7 SLC15A3 NDUFB4 SLC4A5 SLC29A1 | 1.71e-08 | 301 | 59 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 2.05e-08 | 59 | 59 | 6 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 2.05e-08 | 59 | 59 | 6 | GO:0015932 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 1.32e-06 | 188 | 59 | 7 | GO:0015078 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.51e-06 | 207 | 59 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.59e-06 | 208 | 59 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | uniporter activity | 2.90e-06 | 10 | 59 | 3 | GO:0015292 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.09e-06 | 81 | 59 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CNNM2 SLC17A3 SLC12A9 SLC39A1 SLC5A6 SLC9B2 SLC17A7 SLC4A5 SLC29A1 | 8.34e-06 | 465 | 59 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.12e-05 | 171 | 59 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 2.30e-05 | 19 | 59 | 3 | GO:0015355 | |
| GeneOntologyMolecularFunction | uracil transmembrane transporter activity | 2.57e-05 | 3 | 59 | 2 | GO:0015210 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 3.14e-05 | 21 | 59 | 3 | GO:0005326 | |
| GeneOntologyMolecularFunction | cytidine transmembrane transporter activity | 5.13e-05 | 4 | 59 | 2 | GO:0015212 | |
| GeneOntologyMolecularFunction | purine nucleoside transmembrane transporter activity | 5.13e-05 | 4 | 59 | 2 | GO:0015211 | |
| GeneOntologyMolecularFunction | guanine transmembrane transporter activity | 5.13e-05 | 4 | 59 | 2 | GO:0015208 | |
| GeneOntologyMolecularFunction | antiporter activity | 5.44e-05 | 138 | 59 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 5.76e-05 | 71 | 59 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 8.34e-05 | 151 | 59 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 8.53e-05 | 5 | 59 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | membrane potential driven uniporter activity | 8.53e-05 | 5 | 59 | 2 | GO:0022810 | |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 1.28e-04 | 6 | 59 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.45e-04 | 90 | 59 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.50e-04 | 171 | 59 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 1.79e-04 | 7 | 59 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 2.38e-04 | 8 | 59 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.63e-04 | 105 | 59 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 3.05e-04 | 9 | 59 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 3.80e-04 | 10 | 59 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 3.80e-04 | 10 | 59 | 2 | GO:0005337 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.47e-04 | 334 | 59 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 4.64e-04 | 11 | 59 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 4.64e-04 | 11 | 59 | 2 | GO:0015165 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 5.56e-04 | 12 | 59 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 7.63e-04 | 14 | 59 | 2 | GO:0005338 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 2.27e-03 | 24 | 59 | 2 | GO:0005315 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 2.46e-03 | 25 | 59 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 2.67e-03 | 26 | 59 | 2 | GO:0000295 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.74e-03 | 197 | 59 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 2.87e-03 | 27 | 59 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 3.31e-03 | 29 | 59 | 2 | GO:0015216 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 4.27e-03 | 33 | 59 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 4.27e-03 | 33 | 59 | 2 | GO:0015215 | |
| GeneOntologyMolecularFunction | channel activity | 4.45e-03 | 525 | 59 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.49e-03 | 526 | 59 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 5.07e-03 | 36 | 59 | 2 | GO:0090482 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 5.93e-03 | 39 | 59 | 2 | GO:0015605 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 6.54e-03 | 41 | 59 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 6.85e-03 | 42 | 59 | 2 | GO:0042887 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 7.17e-03 | 43 | 59 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.40e-02 | 61 | 59 | 2 | GO:1901682 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | SPNS1 SLC17A3 SLC35A4 SLC17A9 SLC35D2 SLC15A3 SLC29A2 SLC29A1 | 2.99e-10 | 96 | 59 | 8 | GO:1901264 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC32A1 SLC43A2 SLC38A10 SLC17A3 SLC17A9 SLC35D2 SLC5A6 SLC17A7 SLCO3A1 SLC52A2 SLC16A7 SLC4A5 SLC16A12 | 1.79e-09 | 515 | 59 | 13 | GO:0015711 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP5MC1 ATP5MC2 SLC32A1 CNNM2 ROMO1 SLC17A3 SLC12A9 SLC39A1 SLC5A6 ABCB8 SLC9B2 TMEM63C TMEM150C SLC17A7 SLCO3A1 CRACR2B SLC15A3 SLC4A5 | 2.80e-08 | 1374 | 59 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP5MC1 ATP5MC2 SLC32A1 CNNM2 ROMO1 SLC17A3 SLC12A9 SLC39A1 SLC5A6 ABCB8 SLC9B2 TMEM63C SLC17A7 SLC15A3 SLC4A5 | 4.25e-08 | 942 | 59 | 15 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP5MC1 ATP5MC2 SLC32A1 CNNM2 ROMO1 SLC17A3 SLC12A9 SLC39A1 SLC5A6 ABCB8 SLC9B2 TMEM63C TMEM150C SLC17A7 SLC15A3 SLC4A5 | 5.80e-08 | 1115 | 59 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP5MC1 ATP5MC2 SLC32A1 CNNM2 ROMO1 SLC17A3 SLC12A9 SLC39A1 SLC5A6 ABCB8 SLC9B2 TMEM63C SLC17A7 CRACR2B SLC15A3 SLC4A5 | 9.65e-08 | 1157 | 59 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.78e-07 | 87 | 59 | 6 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.91e-07 | 88 | 59 | 6 | GO:0010232 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 4.09e-07 | 163 | 59 | 7 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 4.81e-07 | 167 | 59 | 7 | GO:1903825 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP5MC1 ATP5MC2 SLC32A1 CNNM2 SLC17A3 SLC12A9 SLC39A1 SLC5A6 ABCB8 SLC9B2 SLC17A7 SLC15A3 SLC4A5 | 1.56e-06 | 922 | 59 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC32A1 SLC43A2 SLC38A10 SLC35D2 SLC5A6 SLC17A7 SLCO3A1 SLC16A7 SLC16A12 | 2.32e-06 | 410 | 59 | 9 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC32A1 SLC43A2 SLC38A10 SLC35D2 SLC5A6 SLC17A7 SLCO3A1 SLC16A7 SLC16A12 | 2.41e-06 | 412 | 59 | 9 | GO:0015849 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP5MC1 ATP5MC2 SLC32A1 CNNM2 SLC17A3 SLC12A9 SLC39A1 SLC5A6 ABCB8 SLC9B2 SLC17A7 SLC15A3 SLC4A5 | 4.60e-06 | 1017 | 59 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 5.11e-06 | 40 | 59 | 4 | GO:0072530 | |
| GeneOntologyBiologicalProcess | thymine transport | 8.04e-06 | 2 | 59 | 2 | GO:0035364 | |
| GeneOntologyBiologicalProcess | proton transmembrane transport | 9.01e-06 | 170 | 59 | 6 | GO:1902600 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase transmembrane transport | 2.41e-05 | 3 | 59 | 2 | GO:1904082 | |
| GeneOntologyBiologicalProcess | uracil transmembrane transport | 2.41e-05 | 3 | 59 | 2 | GO:1903791 | |
| GeneOntologyBiologicalProcess | negative regulation of growth hormone receptor signaling pathway | 2.41e-05 | 3 | 59 | 2 | GO:0060400 | |
| GeneOntologyBiologicalProcess | uracil transport | 2.41e-05 | 3 | 59 | 2 | GO:0015857 | |
| GeneOntologyBiologicalProcess | hypoxanthine transport | 4.81e-05 | 4 | 59 | 2 | GO:0035344 | |
| GeneOntologyBiologicalProcess | inosine transport | 4.81e-05 | 4 | 59 | 2 | GO:0035340 | |
| GeneOntologyBiologicalProcess | guanine transmembrane transport | 4.81e-05 | 4 | 59 | 2 | GO:1903716 | |
| GeneOntologyBiologicalProcess | cytidine transport | 4.81e-05 | 4 | 59 | 2 | GO:0015861 | |
| GeneOntologyBiologicalProcess | guanine transport | 4.81e-05 | 4 | 59 | 2 | GO:0015854 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 7.63e-05 | 153 | 59 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 7.69e-05 | 249 | 59 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | adenosine transport | 8.00e-05 | 5 | 59 | 2 | GO:0032238 | |
| GeneOntologyBiologicalProcess | purine nucleoside transmembrane transport | 8.00e-05 | 5 | 59 | 2 | GO:0015860 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside transport | 1.20e-04 | 6 | 59 | 2 | GO:0015864 | |
| GeneOntologyBiologicalProcess | uridine transmembrane transport | 1.20e-04 | 6 | 59 | 2 | GO:0015862 | |
| GeneOntologyBiologicalProcess | adenine transport | 1.20e-04 | 6 | 59 | 2 | GO:0015853 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.64e-04 | 180 | 59 | 5 | GO:0015698 | |
| GeneOntologyBiologicalProcess | regulation of growth hormone receptor signaling pathway | 1.67e-04 | 7 | 59 | 2 | GO:0060398 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase transport | 1.67e-04 | 7 | 59 | 2 | GO:0015855 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.77e-04 | 183 | 59 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | nucleoside transmembrane transport | 2.23e-04 | 8 | 59 | 2 | GO:1901642 | |
| GeneOntologyBiologicalProcess | purine nucleobase transmembrane transport | 2.23e-04 | 8 | 59 | 2 | GO:1904823 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 2.59e-04 | 108 | 59 | 4 | GO:0015807 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.20e-04 | 208 | 59 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | vesicle fusion with Golgi apparatus | 3.57e-04 | 10 | 59 | 2 | GO:0048280 | |
| GeneOntologyBiologicalProcess | nucleoside transport | 3.57e-04 | 10 | 59 | 2 | GO:0015858 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 3.87e-04 | 120 | 59 | 4 | GO:0003333 | |
| GeneOntologyBiologicalProcess | neurotransmitter loading into synaptic vesicle | 4.35e-04 | 11 | 59 | 2 | GO:0098700 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 4.41e-04 | 344 | 59 | 6 | GO:0003018 | |
| GeneOntologyBiologicalProcess | metal ion transport | CNNM2 SLC17A3 SLC12A9 SLC39A1 SLC5A6 ABCB8 SLC9B2 SLC17A7 CRACR2B SLC4A5 | 4.95e-04 | 1000 | 59 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | purine nucleobase transport | 5.21e-04 | 12 | 59 | 2 | GO:0006863 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide-sugar transmembrane transport | 5.21e-04 | 12 | 59 | 2 | GO:0090481 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar transmembrane transport | 6.15e-04 | 13 | 59 | 2 | GO:0015780 | |
| GeneOntologyBiologicalProcess | nucleobase transport | 6.15e-04 | 13 | 59 | 2 | GO:0015851 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 8.18e-04 | 64 | 59 | 3 | GO:0042908 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound transmembrane transport | 9.41e-04 | 16 | 59 | 2 | GO:0072531 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.13e-03 | 275 | 59 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 1.19e-03 | 162 | 59 | 4 | GO:0015748 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 1.33e-03 | 19 | 59 | 2 | GO:0006855 | |
| GeneOntologyBiologicalProcess | proton motive force-driven ATP synthesis | 1.45e-03 | 78 | 59 | 3 | GO:0015986 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 1.99e-03 | 87 | 59 | 3 | GO:1902475 | |
| GeneOntologyBiologicalProcess | amino acid transport | 2.35e-03 | 195 | 59 | 4 | GO:0006865 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 2.50e-03 | 26 | 59 | 2 | GO:0060396 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport via multivesicular body sorting pathway | 2.70e-03 | 27 | 59 | 2 | GO:0032511 | |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 2.70e-03 | 27 | 59 | 2 | GO:0071378 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC43A2 CNNM2 SLC5A6 SLC9B2 SLCO3A1 SLC29A2 SLC16A7 SLC4A5 SLC29A1 SLC16A12 | 1.99e-08 | 320 | 59 | 10 | GO:0016323 |
| GeneOntologyCellularComponent | basal plasma membrane | SLC43A2 CNNM2 SLC5A6 SLC9B2 SLCO3A1 SLC29A2 SLC16A7 SLC4A5 SLC29A1 SLC16A12 | 5.14e-08 | 354 | 59 | 10 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | SLC43A2 CNNM2 SLC5A6 SLC9B2 SLCO3A1 SLC29A2 SLC16A7 SLC4A5 SLC29A1 SLC16A12 | 9.48e-08 | 378 | 59 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | mitochondrial inner membrane | 2.48e-04 | 593 | 59 | 8 | GO:0005743 | |
| GeneOntologyCellularComponent | apical plasma membrane | 4.27e-04 | 487 | 59 | 7 | GO:0016324 | |
| GeneOntologyCellularComponent | organelle inner membrane | 4.68e-04 | 652 | 59 | 8 | GO:0019866 | |
| GeneOntologyCellularComponent | proton-transporting ATP synthase complex, coupling factor F(o) | 6.97e-04 | 14 | 59 | 2 | GO:0045263 | |
| GeneOntologyCellularComponent | clathrin-sculpted vesicle | 9.16e-04 | 16 | 59 | 2 | GO:0060198 | |
| GeneOntologyCellularComponent | apical part of cell | 1.34e-03 | 592 | 59 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | dendrite terminus | 1.44e-03 | 20 | 59 | 2 | GO:0044292 | |
| GeneOntologyCellularComponent | proton-transporting ATP synthase complex | 1.91e-03 | 23 | 59 | 2 | GO:0045259 | |
| GeneOntologyCellularComponent | proton-transporting two-sector ATPase complex, proton-transporting domain | 2.44e-03 | 26 | 59 | 2 | GO:0033177 | |
| GeneOntologyCellularComponent | mitochondrial membrane | 2.87e-03 | 866 | 59 | 8 | GO:0031966 | |
| Domain | MFS_dom | SLC43A2 SPNS1 SLC17A3 SLC17A9 SLC17A7 SLCO3A1 SLC49A3 SLC15A3 SLC29A2 SLC16A7 SLC29A1 SVOPL SLC16A12 | 2.25e-16 | 134 | 59 | 13 | IPR020846 |
| Domain | MFS | SLC43A2 SPNS1 SLC17A3 SLC17A9 SLC17A7 SLC49A3 SLC16A7 SVOPL SLC16A12 | 2.26e-12 | 77 | 59 | 9 | IPR011701 |
| Domain | MFS_1 | SLC43A2 SPNS1 SLC17A3 SLC17A9 SLC17A7 SLC49A3 SLC16A7 SVOPL SLC16A12 | 2.26e-12 | 77 | 59 | 9 | PF07690 |
| Domain | MFS | SLC43A2 SPNS1 SLC17A3 SLC17A9 SLC17A7 SLC49A3 SLC16A7 SVOPL SLC16A12 | 5.09e-11 | 108 | 59 | 9 | PS50850 |
| Domain | Vps55 | 9.81e-06 | 2 | 59 | 2 | PF04133 | |
| Domain | VPS55 | 9.81e-06 | 2 | 59 | 2 | IPR007262 | |
| Domain | ATP_synth_F0_csu_DDCD_BS | 2.94e-05 | 3 | 59 | 2 | IPR020537 | |
| Domain | - | 2.94e-05 | 3 | 59 | 2 | 1.20.20.10 | |
| Domain | ATPASE_C | 2.94e-05 | 3 | 59 | 2 | PS00605 | |
| Domain | ATP_synth_F0_csu | 5.86e-05 | 4 | 59 | 2 | IPR000454 | |
| Domain | Eqnu_transpt | 5.86e-05 | 4 | 59 | 2 | IPR002259 | |
| Domain | Nucleoside_tran | 5.86e-05 | 4 | 59 | 2 | PF01733 | |
| Domain | ATP-synt_C | 9.75e-05 | 5 | 59 | 2 | PF00137 | |
| Domain | ATPase_proteolipid_c-like_dom | 9.75e-05 | 5 | 59 | 2 | IPR002379 | |
| Domain | Tetraspanin | 1.39e-04 | 32 | 59 | 3 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 1.39e-04 | 32 | 59 | 3 | IPR008952 | |
| Domain | Tetraspannin | 1.53e-04 | 33 | 59 | 3 | PF00335 | |
| Domain | Tetraspanin/Peripherin | 1.53e-04 | 33 | 59 | 3 | IPR018499 | |
| Domain | Yip1 | 2.04e-04 | 7 | 59 | 2 | PF04893 | |
| Domain | Yip1 | 2.04e-04 | 7 | 59 | 2 | IPR006977 | |
| Domain | Aa_trans | 1.29e-03 | 17 | 59 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 1.29e-03 | 17 | 59 | 2 | IPR013057 | |
| Domain | Tetraspanin_CS | 1.98e-03 | 21 | 59 | 2 | IPR018503 | |
| Domain | TM4_1 | 3.04e-03 | 26 | 59 | 2 | PS00421 | |
| Domain | ADAM_Cys-rich | 3.27e-03 | 27 | 59 | 2 | IPR006586 | |
| Domain | ACR | 3.27e-03 | 27 | 59 | 2 | SM00608 | |
| Domain | Peptidase_M12B_N | 6.74e-03 | 39 | 59 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.74e-03 | 39 | 59 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 7.08e-03 | 40 | 59 | 2 | PS00427 | |
| Domain | ADAM_MEPRO | 7.08e-03 | 40 | 59 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 7.08e-03 | 40 | 59 | 2 | PS50214 | |
| Domain | Reprolysin | 7.08e-03 | 40 | 59 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 7.08e-03 | 40 | 59 | 2 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 7.43e-03 | 41 | 59 | 2 | PS00546 | |
| Domain | Disintegrin_dom | 7.43e-03 | 41 | 59 | 2 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 8.15e-03 | 43 | 59 | 2 | IPR001818 | |
| Domain | KAZAL | 9.29e-03 | 46 | 59 | 2 | SM00280 | |
| Domain | KAZAL_2 | 1.09e-02 | 50 | 59 | 2 | PS51465 | |
| Domain | Kazal_dom | 1.13e-02 | 51 | 59 | 2 | IPR002350 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC32A1 SLC43A2 SLC39A1 SLC35D2 SLC5A6 SLC17A7 SLCO3A1 SLC15A3 SLC29A2 SLC16A7 SLC4A5 SLC29A1 | 1.61e-13 | 238 | 34 | 12 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC32A1 SLC43A2 SLC39A1 SLC35D2 SLC5A6 SLC17A7 SLCO3A1 SLC15A3 SLC29A2 SLC16A7 SLC4A5 SLC29A1 | 2.75e-13 | 249 | 34 | 12 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC32A1 SLC43A2 SLC17A3 SLC39A1 SLC35D2 SLC5A6 ABCB8 SLC9B2 SLC17A7 SLCO3A1 SLC15A3 SLC29A2 SLC16A7 SLC4A5 SLC29A1 | 1.23e-11 | 681 | 34 | 15 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC32A1 SLC43A2 SLC17A3 SLC39A1 SLC35D2 SLC5A6 ABCB8 SLC9B2 SLC17A7 SLCO3A1 SLC15A3 SLC29A2 SLC16A7 SLC4A5 SLC29A1 | 3.72e-11 | 736 | 34 | 15 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 4.23e-08 | 41 | 34 | 5 | MM15075 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 5.41e-08 | 43 | 34 | 5 | M881 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.61e-06 | 108 | 34 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.87e-06 | 109 | 34 | 5 | MM15074 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 3.06e-04 | 11 | 34 | 2 | MM15471 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 3.67e-04 | 12 | 34 | 2 | M27728 | |
| Pathway | WP_OXIDATIVE_PHOSPHORYLATION | 3.99e-04 | 60 | 34 | 3 | M39436 | |
| Pathway | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | 1.04e-03 | 20 | 34 | 2 | M11716 | |
| Pathway | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | 1.27e-03 | 22 | 34 | 2 | MM14626 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 1.38e-03 | 23 | 34 | 2 | M45013 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 1.91e-03 | 27 | 34 | 2 | MM15693 | |
| Pathway | WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA | 2.03e-03 | 105 | 34 | 3 | M39417 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 2.84e-03 | 33 | 34 | 2 | MM14608 | |
| Pathway | REACTOME_CRISTAE_FORMATION | 2.84e-03 | 33 | 34 | 2 | M27818 | |
| Pathway | KEGG_PARKINSONS_DISEASE | 3.72e-03 | 130 | 34 | 3 | M7272 | |
| Pathway | KEGG_OXIDATIVE_PHOSPHORYLATION | 3.88e-03 | 132 | 34 | 3 | M19540 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | ATP5MC2 SLC32A1 SLC43A2 SPNS1 YIPF5 SLC35A4 SLC39A1 SLC5A6 LEPROT SLC52A2 SLC29A1 | 2.26e-08 | 697 | 59 | 11 | 28298427 |
| Pubmed | 1.62e-07 | 7 | 59 | 3 | 29949744 | ||
| Pubmed | ATP5MC2 SLC43A2 SLC39A1 SLC5A6 LDAF1 LEPROTL1 TSPAN14 LEPROT | 6.54e-07 | 430 | 59 | 8 | 16303743 | |
| Pubmed | 1.00e-06 | 105 | 59 | 5 | 30280653 | ||
| Pubmed | 1.67e-06 | 14 | 59 | 3 | 36573432 | ||
| Pubmed | 1.90e-06 | 52 | 59 | 4 | 26590417 | ||
| Pubmed | Excitatory neuronal CHD8 in the regulation of neocortical development and sensory-motor behaviors. | 2.56e-06 | 16 | 59 | 3 | 33626347 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 10722669 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 37953348 | ||
| Pubmed | LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice. | 2.83e-06 | 2 | 59 | 2 | 19907080 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 34503974 | ||
| Pubmed | Repression of the equilibrative nucleoside transporters dampens inflammatory lung injury. | 2.83e-06 | 2 | 59 | 2 | 23590299 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 27160886 | ||
| Pubmed | A membrane protein enriched in endoplasmic reticulum exit sites interacts with COPII. | 2.83e-06 | 2 | 59 | 2 | 11489904 | |
| Pubmed | Differential expression of hENT1 and hENT2 in colon cancer cell lines. | 2.83e-06 | 2 | 59 | 2 | 28218790 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12006583 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21396926 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8986748 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23639800 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 15649894 | ||
| Pubmed | Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1). | 2.83e-06 | 2 | 59 | 2 | 21795683 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8485160 | ||
| Pubmed | Time of day-dependent sorting of the vesicular glutamate transporter to the plasma membrane. | 2.83e-06 | 2 | 59 | 2 | 19103593 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 11179696 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 34083383 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 9396714 | ||
| Pubmed | Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer. | 2.83e-06 | 2 | 59 | 2 | 31601121 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17921321 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 11085929 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12527552 | ||
| Pubmed | The PrLGlu→avBNSTGABA circuit rapidly modulates depression-like behaviors in male mice. | 2.83e-06 | 2 | 59 | 2 | 37810240 | |
| Pubmed | 3.72e-06 | 18 | 59 | 3 | 16606357 | ||
| Pubmed | 4.41e-06 | 19 | 59 | 3 | 28066179 | ||
| Pubmed | Appearance of new tetraspanin genes during vertebrate evolution. | 5.18e-06 | 20 | 59 | 3 | 18291621 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 28289229 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 31914698 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 18703227 | ||
| Pubmed | Presynaptic CLC-3 determines quantal size of inhibitory transmission in the hippocampus. | 8.48e-06 | 3 | 59 | 2 | 21378974 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 23603835 | ||
| Pubmed | Glutamatergic and GABAergic innervation of human gonadotropin-releasing hormone-I neurons. | 8.48e-06 | 3 | 59 | 2 | 22510271 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 19297449 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 26159773 | ||
| Pubmed | Targeting ENT1 and adenosine tone for the treatment of Huntington's disease. | 8.48e-06 | 3 | 59 | 2 | 28069792 | |
| Pubmed | Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors. | 8.48e-06 | 3 | 59 | 2 | 15386342 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 37542722 | ||
| Pubmed | Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior. | 9.15e-06 | 24 | 59 | 3 | 29086765 | |
| Pubmed | Sequence analysis and mapping of a novel human mitochondrial ATP synthase subunit 9 cDNA (ATP5G3). | 1.69e-05 | 4 | 59 | 2 | 7698763 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 17651422 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 24790209 | ||
| Pubmed | Nucleoside transporters are widely expressed in ovarian carcinoma effusions. | 1.69e-05 | 4 | 59 | 2 | 21822668 | |
| Pubmed | Sequences of members of the human gene family for the c subunit of mitochondrial ATP synthase. | 1.69e-05 | 4 | 59 | 2 | 8328972 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 12446811 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 18635603 | ||
| Pubmed | Posterior amygdala regulates sexual and aggressive behaviors in male mice. | 1.69e-05 | 4 | 59 | 2 | 32719562 | |
| Pubmed | A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. | 1.69e-05 | 4 | 59 | 2 | 17823315 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 12820662 | ||
| Pubmed | A locus coeruleus to dentate gyrus noradrenergic circuit modulates aversive contextual processing. | 1.69e-05 | 4 | 59 | 2 | 34081911 | |
| Pubmed | Human liver cDNA clones encoding proteolipid subunit 9 of the mitochondrial ATPase complex. | 1.69e-05 | 4 | 59 | 2 | 2883974 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 17926640 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 37288658 | ||
| Pubmed | Protocol to map multi-transmitter neurons in the mouse brain using intersectional strategy. | 2.82e-05 | 5 | 59 | 2 | 36595933 | |
| Pubmed | A photoswitchable GPCR-based opsin for presynaptic inhibition. | 2.82e-05 | 5 | 59 | 2 | 33979635 | |
| Pubmed | Acute knockdown of Depdc5 leads to synaptic defects in mTOR-related epileptogenesis. | 2.82e-05 | 5 | 59 | 2 | 32113911 | |
| Pubmed | A neural circuit for excessive feeding driven by environmental context in mice. | 4.23e-05 | 6 | 59 | 2 | 34168339 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 32209486 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 35237119 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 27272503 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 24987331 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 23035126 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 26686862 | ||
| Pubmed | Control of excitatory and inhibitory synapse formation by neuroligins. | 7.87e-05 | 8 | 59 | 2 | 15681343 | |
| Pubmed | Modulation of tactile feedback for the execution of dexterous movement. | 7.87e-05 | 8 | 59 | 2 | 34648327 | |
| Pubmed | PRISM: A Progenitor-Restricted Intersectional Fate Mapping Approach Redefines Forebrain Lineages. | 7.87e-05 | 8 | 59 | 2 | 32574593 | |
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 30201312 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 23652595 | ||
| Pubmed | Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent. | 7.87e-05 | 8 | 59 | 2 | 28169986 | |
| Pubmed | Cortical regulation of neurogenesis and cell proliferation in the ventral subventricular zone. | 7.87e-05 | 8 | 59 | 2 | 37422764 | |
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 21356198 | ||
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 18986540 | ||
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 24803543 | ||
| Pubmed | 1.26e-04 | 10 | 59 | 2 | 27713499 | ||
| Pubmed | 1.26e-04 | 10 | 59 | 2 | 23091066 | ||
| Pubmed | P/Q Type Calcium Channel Cav2.1 Defines a Unique Subset of Glomeruli in the Mouse Olfactory Bulb. | 1.54e-04 | 11 | 59 | 2 | 30233329 | |
| Pubmed | 1.54e-04 | 11 | 59 | 2 | 30232223 | ||
| Pubmed | 1.85e-04 | 12 | 59 | 2 | 33786818 | ||
| Pubmed | NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation. | 1.85e-04 | 12 | 59 | 2 | 16980967 | |
| Pubmed | The Complement Regulator Susd4 Influences Nervous-System Function and Neuronal Morphology in Mice. | 1.85e-04 | 12 | 59 | 2 | 32179479 | |
| Pubmed | Roles of BLOC-1 and adaptor protein-3 complexes in cargo sorting to synaptic vesicles. | 1.85e-04 | 12 | 59 | 2 | 19144828 | |
| Pubmed | Kinase signalling in excitatory neurons regulates sleep quantity and depth. | 1.85e-04 | 12 | 59 | 2 | 36477539 | |
| Pubmed | A shared vesicular carrier allows synaptic corelease of GABA and glycine. | 1.85e-04 | 12 | 59 | 2 | 16701208 | |
| Pubmed | Effect of riboflavin deficiency on development of the cerebral cortex in Slc52a3 knockout mice. | 1.85e-04 | 12 | 59 | 2 | 33116204 | |
| Pubmed | Contribution of adenosine related genes to the risk of depression with disturbed sleep. | 2.18e-04 | 13 | 59 | 2 | 20392501 | |
| Pubmed | 2.18e-04 | 13 | 59 | 2 | 33963279 | ||
| Pubmed | Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders. | 2.18e-04 | 13 | 59 | 2 | 29488136 | |
| Pubmed | 2.18e-04 | 13 | 59 | 2 | 16814779 | ||
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 9461222 | ||
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 12739169 | ||
| Pubmed | Retinoic acid functions as a key GABAergic differentiation signal in the basal ganglia. | 2.54e-04 | 14 | 59 | 2 | 21532733 | |
| Pubmed | Translation of 5' leaders is pervasive in genes resistant to eIF2 repression. | 2.54e-04 | 14 | 59 | 2 | 25621764 | |
| Pubmed | Transcription profile during maternal to zygotic transition in the mouse embryo. | 2.54e-04 | 14 | 59 | 2 | 16930510 | |
| Interaction | CLEC2D interactions | 1.51e-06 | 197 | 58 | 7 | int:CLEC2D | |
| Interaction | GP5 interactions | 3.45e-05 | 64 | 58 | 4 | int:GP5 | |
| Cytoband | 17p13.3 | 2.05e-04 | 88 | 59 | 3 | 17p13.3 | |
| Cytoband | 5q31.3 | 9.95e-04 | 36 | 59 | 2 | 5q31.3 | |
| GeneFamily | Solute carriers | SLC32A1 SLC43A2 SLC38A10 SLC17A3 SLC12A9 SLC35A4 SLC39A1 SLC17A9 SLC35D2 SLC5A6 SLC9B2 SLC17A7 SLCO3A1 SLC49A3 SLC52A2 SLC15A3 SLC29A2 SLC16A7 SLC4A5 SLC29A1 SLC25A51 SLC16A12 | 1.13e-25 | 395 | 43 | 22 | 752 |
| GeneFamily | CD molecules|Tetraspanins | 6.50e-05 | 33 | 43 | 3 | 768 | |
| GeneFamily | Yip1 domain containing | 1.15e-04 | 7 | 43 | 2 | 105 | |
| GeneFamily | F-type ATPases|Mitochondrial complex V: ATP synthase subunits | 8.25e-04 | 18 | 43 | 2 | 416 | |
| GeneFamily | F-type ATPases|Mitochondrial complex V: ATP synthase subunits | 9.21e-04 | 19 | 43 | 2 | 644 | |
| GeneFamily | Olfactory receptors, family 1 | 4.07e-03 | 40 | 43 | 2 | 147 | |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN | 3.62e-06 | 187 | 58 | 6 | M8589 | |
| Coexpression | GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN | 5.03e-06 | 198 | 58 | 6 | M6224 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN | 7.20e-05 | 195 | 58 | 5 | M3327 | |
| Coexpression | GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP | 7.93e-05 | 199 | 58 | 5 | M4427 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN | 7.93e-05 | 199 | 58 | 5 | M4457 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP | 7.93e-05 | 199 | 58 | 5 | M3876 | |
| Coexpression | GSE45837_WT_VS_GFI1_KO_PDC_DN | 8.12e-05 | 200 | 58 | 5 | M9894 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | SLC38A10 CNNM2 CWH43 CYB561D2 TMEM150C SLCO3A1 CRACR2B SLC25A51 SVOPL SLC16A12 | 4.52e-05 | 811 | 56 | 10 | gudmap_developingKidney_e15.5_S-shaped body_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.39e-05 | 160 | 56 | 5 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#4_top-relative-expression-ranked_500 | 9.81e-05 | 34 | 56 | 3 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k4 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.13e-07 | 107 | 59 | 5 | 13af691c8533418d2800a8eca61155896b559948 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.13e-07 | 107 | 59 | 5 | a5a34bb9706527799ddb494d4f1bfc634c29e8a9 | |
| ToppCell | severe_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 1.32e-06 | 143 | 59 | 5 | 28b0e168126a9fe60541dc12bfab385b7a0a2342 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 177 | 59 | 5 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 5.04e-06 | 188 | 59 | 5 | 15057036b46c9df621ec4955aa94ca3036245d45 | |
| ToppCell | CTRL-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 5.44e-06 | 191 | 59 | 5 | 32381d353e40bce77a5b63c7bdbe360d27327d86 | |
| ToppCell | facs-Tongue-nan-18m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-06 | 193 | 59 | 5 | 45361266b5c6e9b229ef80ef692f01b48e5b38ed | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-4|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.87e-06 | 194 | 59 | 5 | 12d5ca5b6d9f6b3a191303846e71dca0ce4fc97d | |
| ToppCell | severe_COVID-19-B_cell|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.99e-05 | 144 | 59 | 4 | c7f696e55e2d959c58ec32640c71ef86ee25203c | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-7|TCGA-Liver / Sample_Type by Project: Shred V9 | 5.88e-05 | 159 | 59 | 4 | 70288df54adab167c0f50675128619299077db11 | |
| ToppCell | control-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 160 | 59 | 4 | f49c810072604c4dee51025073c9e088c00daf4a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-05 | 160 | 59 | 4 | 1e210e526ea4d84fc58a798a26c0929bcb69fd89 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.44e-05 | 169 | 59 | 4 | 2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-05 | 172 | 59 | 4 | 87a30a219b0a6979abb5fba292a2d8ea946fd849 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-05 | 172 | 59 | 4 | 5030ac31709cac236bb58f4ef9d545d24690411a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 173 | 59 | 4 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 8.15e-05 | 173 | 59 | 4 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.52e-05 | 175 | 59 | 4 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.52e-05 | 175 | 59 | 4 | 69ed3c7c45df6bef70f5f2ff003531160bf3b32b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.71e-05 | 176 | 59 | 4 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(INS+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.71e-05 | 176 | 59 | 4 | 6b04672f295d7680ba00714a72785314a619c893 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 179 | 59 | 4 | b88791dd4e73bb8410ca090938a1a45b0bc16e69 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 179 | 59 | 4 | c063028b82c68d929aef2421daade9dc189a6963 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 180 | 59 | 4 | cd743f81838ba210e5bb63fe0870918d7d2b0112 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 180 | 59 | 4 | 407fd8f61a757626e082b6e2eefd3a33276e6b71 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 183 | 59 | 4 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 185 | 59 | 4 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 186 | 59 | 4 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 59 | 4 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 59 | 4 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 187 | 59 | 4 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | facs-Tongue-nan-18m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 188 | 59 | 4 | a2fda11bba33ddefa48f93dd635e254d1a081218 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 188 | 59 | 4 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | facs-Tongue-nan-18m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 188 | 59 | 4 | 1b3f71de4631403938a9dc85a02af2feea0b919f | |
| ToppCell | facs-Skin-nan-18m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 190 | 59 | 4 | 313f816c34b4e213eff8f07c7dbb6886b5d6292e | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.17e-04 | 190 | 59 | 4 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | be4114b88a593e8bd905108dc603f62b16c5938b | |
| ToppCell | PBMC-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 1.22e-04 | 192 | 59 | 4 | 385061d6257295bd515dea98f9bcd52374509276 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.29e-04 | 195 | 59 | 4 | dd52d137cceef9b1d56e19f9902ff58e0149b753 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 196 | 59 | 4 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| ToppCell | Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.34e-04 | 197 | 59 | 4 | 598fb7a9a8400af49d90807b3155d3cc1c34f505 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_monocytic-monocyte-MOP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 197 | 59 | 4 | 46569fa40f9c34918d7288d4fa7a2d6efb5c0566 | |
| ToppCell | 10x5'v1-week_12-13|World / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 197 | 59 | 4 | 4b107359f2d703a1d0348932a6b64eb447d30b3d | |
| ToppCell | (08)_Brush+PNEC-(0)_Reference|(08)_Brush+PNEC / shred by cell type by condition | 1.34e-04 | 197 | 59 | 4 | d500bfed2a76f7300f2f17b60962c18a40efd084 | |
| Drug | sodium | ACTL7A SLC32A1 SLC43A2 SPNS1 SLC17A3 SLC12A9 SLC5A6 ABCB8 SLC9B2 SLC17A7 SLCO3A1 SLC29A2 SLC4A5 SLC29A1 | 9.40e-08 | 944 | 59 | 14 | CID000000923 |
| Drug | 3-iodothyronamine | 1.57e-06 | 33 | 59 | 4 | ctd:C487948 | |
| Drug | amiloride | 1.67e-05 | 315 | 59 | 7 | CID000016230 | |
| Drug | bumetanide | 1.67e-05 | 209 | 59 | 6 | CID000002471 | |
| Drug | 4-nitrobenzylthioinosine | 1.98e-05 | 3 | 59 | 2 | ctd:C001789 | |
| Drug | AC1L23IZ | 1.98e-05 | 3 | 59 | 2 | CID000065574 | |
| Drug | AC1LCVXF | 3.95e-05 | 4 | 59 | 2 | CID000638218 | |
| Drug | 170U88 | 3.95e-05 | 4 | 59 | 2 | CID000129338 | |
| Drug | IH-NBMPR | 6.57e-05 | 5 | 59 | 2 | CID000130614 | |
| Drug | SAENTA | 6.57e-05 | 5 | 59 | 2 | CID000164293 | |
| Drug | Inosine | 6.57e-05 | 5 | 59 | 2 | ctd:D007288 | |
| Drug | melarsen | 6.57e-05 | 5 | 59 | 2 | CID000079871 | |
| Drug | 3'-deoxyinosine | 9.84e-05 | 6 | 59 | 2 | CID000159463 | |
| Drug | 5'-deoxythymidine | 9.84e-05 | 6 | 59 | 2 | CID000065120 | |
| Disease | mitochondrial complex V (ATP synthase) deficiency (implicated_via_orthology) | 1.10e-05 | 3 | 57 | 2 | DOID:0111143 (implicated_via_orthology) | |
| Disease | dystonia (implicated_via_orthology) | 2.39e-04 | 12 | 57 | 2 | DOID:543 (implicated_via_orthology) | |
| Disease | azoospermia (implicated_via_orthology) | 1.25e-03 | 27 | 57 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | complex trait | 1.88e-03 | 271 | 57 | 4 | EFO_0010578 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 3.15e-03 | 43 | 57 | 2 | DOID:2476 (implicated_via_orthology) | |
| Disease | fibrinogen measurement, coronary artery disease | 3.32e-03 | 154 | 57 | 3 | EFO_0001645, EFO_0004623 | |
| Disease | schizophrenia, anorexia nervosa | 3.91e-03 | 48 | 57 | 2 | MONDO_0005090, MONDO_0005351 | |
| Disease | migraine disorder | 5.03e-03 | 357 | 57 | 4 | MONDO_0005277 | |
| Disease | interstitial lung disease | 7.48e-03 | 67 | 57 | 2 | EFO_0004244 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLVALSTCSGGFLGM | 121 | O43506 | |
| AILGFALSEAMGLFC | 116 | Q06055 | |
| AILGFALSEAMGLFC | 111 | P05496 | |
| FFGNLMDASKLSLCG | 361 | P36871 | |
| FSTCGGGLMGFIQLN | 236 | Q8TE59 | |
| GMLLGCFTAILIGGF | 131 | O00476 | |
| SFSGAIGLTFLMLGC | 11 | O15243 | |
| LLGSKFISFGGCLMQ | 86 | Q9Y585 | |
| LIFIALALNGFGGMC | 146 | Q8N370 | |
| GTGMELLRLGSLFCY | 556 | Q9P1W3 | |
| GGTALLFFFGWMTLC | 171 | Q63HM2 | |
| CILCGLGFVSLAMSG | 101 | Q96B96 | |
| AGGLLCCLGMVLASF | 91 | O60669 | |
| SFGGAIGLMFLMLGC | 11 | O95214 | |
| NSLMGALCGFGPLIF | 86 | O95168 | |
| MALLLLAGYGCVLGA | 11 | Q86YW7 | |
| GFLTAREFCLGLGMF | 81 | Q8N4Y2 | |
| REFCLGLGMFVGVAS | 86 | Q8N4Y2 | |
| MGIFFCLSGVGSLLG | 496 | Q8IY34 | |
| GGTFRMFLLFAVSLC | 121 | Q9HBR0 | |
| SLALLGGSLGLMFCL | 6 | Q16617 | |
| GGSLGLMFCLIALST | 11 | Q16617 | |
| GYLLGSASLLLGMCS | 166 | O14569 | |
| FNCMVLGTLFIGGSL | 386 | Q9NUT2 | |
| ATGCFIFLTLLGFMT | 201 | P47884 | |
| PFGGAVLLCLASGLM | 236 | Q9H720 | |
| GLNICMAGGLRYSFL | 301 | Q76EJ3 | |
| GALMTFFLALGLSCG | 431 | Q14542 | |
| CGALLFFSSLLMFGF | 271 | Q9UIG8 | |
| CGFSMIFSSVLLGFA | 446 | Q6ZSM3 | |
| IMLSRGLAFGYGLLC | 396 | Q9Y289 | |
| ICGGLLGAMLGFLFF | 216 | Q9H1U9 | |
| MAAGALFGTFSCLRI | 31 | P60602 | |
| GLSLLGVFCGGYLMA | 341 | Q9HAB3 | |
| GSGGLCTLVMAFLAG | 361 | Q86UD5 | |
| GMGLGLSSVFALCLG | 316 | Q9BYT1 | |
| AIMSGLGFCISFGIR | 66 | Q9P2U7 | |
| ALCLASFGMTLLGNF | 106 | B9EJG8 | |
| GAIMAFFLCLGLALG | 431 | Q99808 | |
| CTSSAGLIGFLFMLR | 391 | Q8N434 | |
| GNILLCGGSTMLSGF | 356 | Q9Y615 | |
| ACMFSSILLFGAAGL | 11 | Q9H2A9 | |
| FISLLLCLSGMFSGL | 261 | Q9H8M5 | |
| FAFLMGGQSLCALAQ | 126 | Q6UXD7 | |
| GGRLCFLMLGSLAAG | 601 | Q7RTX1 | |
| FSCMTPLGIGLGAAL | 246 | Q9NY26 | |
| EAQGLMAGGFLCFSL | 86 | Q96QS1 | |
| MKTGLFFLCLLGTAA | 1 | Q14515 | |
| QFSLMLCAFVGALGG | 461 | Q9H2V7 | |
| FAVLFNGCTGIMAGA | 271 | Q9BXP2 | |
| LLLLMAAGACYAAGG | 146 | Q96G79 | |
| SFLGTAMAGSLFCLF | 556 | Q9BY07 | |
| AMAGSLFCLFSGQPL | 561 | Q9BY07 | |
| MVFCLAFGATLLLAG | 131 | Q969M3 | |
| MSCLDSIALGFNFGR | 706 | P11137 | |
| MGPAGCAFTLLLLLG | 1 | Q7RTY5 | |
| VMFILGFAGCIGALR | 71 | P62079 | |
| VMFTLGFAGCVGALR | 71 | Q8NG11 | |
| LMGLTGSLTGAGLCF | 456 | Q9H598 | |
| ILSGCAMFFSLQGIF | 216 | Q8N8F6 | |
| ALGFGRTGTMLACYL | 96 | Q9BVJ7 | |
| GPGLLALSALGFCLM | 11 | Q8N145 |